Total Funding
84
86
Total FundingSeries D raised
Growth Score 84 in past quarter
-9 pts
Heat Score 86 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2269
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
- Stephanie Tagliatela: Co-Founder and Chief Scientific Officer
- Kartik Ramamoorthi: Co-founder, Chief Executive Officer & Board Member
About the Company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad range of severe genetic disorders. The company's therapy pipeline addresses devastating genetic and acquired disorders spanning multiple disease pathways including neurocircuitry, metabolic disorders, neurodegeneration and cardiovascular
disease, enabling medical practitioners to treat patients and improve their lives.
Women Founded